Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Hempdocon Aug 19, 2020 9:38pm
358 Views
Post# 31431619

RE:RE:RE:News release after the bell

RE:RE:RE:News release after the bell

Scorpio2 wrote: Until we know the details of the actual amendments it's difficult to comment but I'm not surprised that they need to amend their by-laws relating to corporate governance standards. We all believe that they are probably weak, consistent with the makeup of the board of directors. A line up of "yes" men. 

 

I think we may suffer from a bit of that "yes men" syndrome on both the BOD & MSAB...in the form of collective complacency &/or one standout personality/title that ends up ruling the roost...I've seen it a million times.

<< Previous
Bullboard Posts
Next >>